← Oncology Approval Tracker

FDA DECISION ·

Bavencio

avelumab · EMD Serono

FDA approvalNew or expanded indicationUrothelial carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Maintenance therapy for locally advanced or metastatic urothelial carcinoma without progression on first-line platinum-containing chemotherapy.

LAMPGEN ANALYSIS

Why it matters

Established switch maintenance with a checkpoint inhibitor after first-line platinum treatment.

What research teams should watch

Capture nonprogression and establish a handoff from chemotherapy to maintenance scheduling.

PRIMARY RECORDS

Sources